Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players√Ę‚ā¨‚ĄĘ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Request Free Sample
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Speak to Analyst

Middle East and Africa Smoking Cessation and Nicotine De-Addiction Market Research Report Information, by Treatment (pharmacological, therapies and others), by Product Type (drugs, inhalers, patches, sprays & gums and others), Distribution Channels (pharmacies, online, de-addiction centers) - Forecast to 2030


ID: MRFR/Pharma/2021-HCR | 80 Pages | Author: Rahul Gotadki| April 2024

Middle East and Africa Smoking Cessation and Nicotine De-Addiction Market Synopsis:


Middle East and Africa Smoking Cessation And Nicotine De-Addiction Market is expected to grow USD 12.65 Billion at a CAGR 14.20% during the forcast period 2023 to 2030. 


Market Scenario


Smoking cessation and nicotine de-addiction are drugs and therapies used in the treatment of withdrawal symptoms associated with the cessation of nicotine. According to the World Health Organization tobacco kills around 6 million people each year and of these almost 5 million deaths are the result of direct tobacco use and approximately 600,000 are the result of passive smoking. Tobacco also derives its users of income, raises healthcare cost and hinder economic development.


Nicotine use also is a risk factor for many diseases and disorders such as cardiovascular diseases, cancer etc. Green tobacco sickness, caused by nicotine absorption through the skin by the handling of wet tobacco leaves in tobacco industry is also a concern especially among children. Tobacco quitting assistance in the form of national cessation services with cost-coverage are available in only 24 countries, representing 15% of the world's population. Only 42 countries, representing 19% of the world's population, have instituted advertisement regulations such as pictorial warnings.


The other market driving factors include increasing desire and drives to quit smoking and active role of social and health organizations against tobacco use, the prohibitive costs due to high taxes leveraged on tobacco products, social stigma imposed on tobacco users etc. The other critical market driving factor is the huge number of unmet needs. The World Health Organization (WHO), estimates around 1,100 million smokers worldwide with emerging economies accounting for around 70% of the global smoker population.


The market trends include development of better products such as nicotine gums and patches, e-cigarette’s etc.


The market for Middle East and Africa smoking cessation and nicotine de-addiction was estimated to be around $ 1040 million in 2016. Taking all factors into consideration, we expect the Middle East and Africa smoking cessation and nicotine de-addiction market to reach around USD 12.65 Billion, by 2030 growing at a CAGR of 14.20% 


Study Objectives of Middle East and Africa Smoking Cessation and Nicotine De-Addiction Market



  • To provide detail analysis of the market structure along with forecast for the next 6 years of various segments and sub-segments of the Middle East and Africa smoking cessation and nicotine de-addiction market.

  • To provide insights about factors affecting the market growth.

  • To analyze the market based on various analyses which includes price analysis, supply chain analysis, Porters Five Force analysis etc.

  • To provide past and estimated future revenue of Middle East and Africa smoking cessation and nicotine de-addiction market‚Äôs segments and sub-segments. To provide country level analysis of the market with respect to the current market size and future growth prospect.

  • To provide country level analysis of the Middle East and Africa smoking cessation and nicotine de-addiction market by treatment (pharmacological, therapies and others), by product type (drugs, inhalers, patches, sprays and gums and others) and by distribution channels (pharmacies, online, de-addiction centers) and other sub segments.

  • To provide overview of key players and their strategic profiling in the market; comprehensively analyzing their core competencies and drawing a competitive landscape of the market

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments along with research and developments globally.¬†


Middle East and Africa Smoking Cessation and Nicotine De-Addiction Market, by Treatment, 2016 (% market share) Smoking Cessation And Nicotine De-Addiction Market


Intended Audience



  • Smoking cessation and nicotine de-addiction products manufacturers

  • Smoking cessation and nicotine de-addiction products suppliers

  • Market research and consulting service providers

  • De-Addiction centers


Key Players of Middle East and Africa Smoking Cessation and Nicotine De-Addiction Market Some of the key players in this market are Pfizer Inc, VMR Products LLC, Johnson & Johnson, Novartis International AG, Cipla Inc., and GlaxoSmithKline plc. Nicotek LLC., and Lorillard, Inc. and others.


Segments:Middle East and Africa smoking cessation and nicotine de-addiction products market has been segmented on the basis of treatment which comprises of pharmacological, therapies etc. On the basis of product type; market is segmented into drugs, inhalers, patches, sprays and gums and others. On the basis of distribution channels; market is segmented into pharmacies, online and de-addiction centers.


Regional Analysis of Middle East and Africa Smoking Cessation and Nicotine De-Addiction Market UAE is the largest market in the entire Middle East and Africa smoking cessation and nicotine de-addiction products market closely followed by Egypt. Algeria and South Africa followed by Ethiopia are fastest growing markets in Africa. The rest of Africa market however has maximum population with unmet medical needs.


The report for Middle East and Africa smoking cessation and nicotine de-addiction market by Market Research Future comprises extensive primary research along with detail analysis of qualitative as well as quantitative aspects given by  various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a  clear picture of current market scenario which includes past and estimated future market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provide detail information about and strategies used by top key players in the industry. The report also gives a broad study of different markets segments and regions.

Report Attribute/Metric Details
  Market Size  12.65 Billion
  CAGR 14.20%
  Base Year   2022
  Forecast Period   2023-2030
  Historical Data   2021
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered Treatment,Product Type ,Distribution Channels
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors Pfizer Inc, VMR Products LLC, Johnson & Johnson, Novartis International AG, Cipla Inc., and GlaxoSmithKline plc. Nicotek LLC., and Lorillard, Inc. and others.
  Key Market Opportunities  
  Key Market Drivers  increasing desire and drives to quit smoking and active role of social and health organizations against tobacco use


Frequently Asked Questions (FAQ) :

Middle East and Africa Smoking Cessation and Nicotine De-Addiction Market is projected to grow at a 14.20% CAGR between 2023-2030.

The UAE is predicted to dominate the Middle East and Africa Smoking Cessation and Nicotine De-Addiction Market.

Middle East and Africa Smoking Cessation and Nicotine De-Addiction Market is predicted to touch USD 12.65 Billion by 2030.

E-cigarettes and nicotine patches and gums are the latest trends in the Middle East and Africa Smoking Cessation and Nicotine De-Addiction Market.

Key competitors in the Middle East and Africa Smoking Cessation and Nicotine De-Addiction Market include Lorillard, Inc., GlaxoSmithKline plc. Nicotek LLC, Cipla Inc., Novartis International AG, Johnson & Johnson, VMR Products LLC, and Pfizer Inc.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Request Free Sample
Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.
Ask for Customization